Related content

Sunny outlook for personalized medicine: tamoxifen and beyond

By Teft Wendy A   Kim Richard B  

Pharmacogenomics, Vol. 14, Iss. 13, 2013-10 ,pp. : 1533-1536

Future Medicine

Access to resources Recommend Favorite

Pharmacogenomics of IFN-&bgr;β in multiple sclerosis: towards a personalized medicine approach

By Vosslamber Saskia   van Baarsen Lisa GM   Verweij Cornelis L  

Pharmacogenomics, Vol. 10, Iss. 1, 2009-01 ,pp. : 97-108

Future Medicine

Access to resources Recommend Favorite

Pharmacogenetics of disease-modifying antirheumatic drugs in rheumatoid arthritis: towards personalized medicine

By Umićević Mirkov Maša   Coenen Marieke JH  

Pharmacogenomics, Vol. 14, Iss. 4, 2013-03 ,pp. : 425-444

Future Medicine

Access to resources Recommend Favorite

Editorial (Nutriproteomics and Proteogenomics: Cultivating Two Novel Hybrid Fields of Personalized Medicine with Added Societal Value)

By  

Current Pharmacogenomics and Personalized Medicine (Formerly Current Pharmacogenomics), Vol. 8, Iss. 4, 2010-12 ,pp. : 240-244

Bentham Science Publishers

Access to resources Recommend Favorite

Editorial (Thematic Issue: Molecular Image-Guided Cancer Treatment: Moving Towards Personalized Medicine-Part II)

By  

Current Pharmaceutical Biotechnology, Vol. 14, Iss. 8, 2013-10 ,pp. : 713-713

Bentham Science Publishers

Access to resources Recommend Favorite